These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15380602)

  • 1. Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.
    Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):648-53. PubMed ID: 15380602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.
    Kunogi H; Cunha JAM; Chang AJ; Gadzinski AJ; Shinohara K; Hsu IC
    Brachytherapy; 2017; 16(6):1113-1118. PubMed ID: 28869143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy in patients with small prostate glands.
    Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
    Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.
    Brousil P; Hussain M; Lynch M; Laing RW; Langley SE
    BJU Int; 2015 Apr; 115(4):580-6. PubMed ID: 24802744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
    Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
    Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
    Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
    BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW
    Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
    Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
    J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
    Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
    Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate brachytherapy can be performed in selected patients after transurethral resection of the prostate.
    Moran BJ; Stutz MA; Gurel MH
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):392-6. PubMed ID: 15145153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients.
    Reed DR; Wallner KE; Narayanan S; Sutlief SG; Ford EC; Cho PS
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):301-7. PubMed ID: 16111600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer.
    Luo HL; Fang FM; Chuang YC; Chiang PH
    BJU Int; 2009 Dec; 104(11):1620-3. PubMed ID: 19624535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer.
    Flam TA; Peyromaure M; Chauveinc L; Thiounn N; Firmin F; Cosset JM; Bernard D
    J Urol; 2004 Jul; 172(1):108-11. PubMed ID: 15201748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
    Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
    Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.